Who Owns OnKure Therapeutics Stock?
NASDAQ: OKURHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 86.75%
- Held by insiders
- 10.17%
- Institutional holders
- 101
- Institutions 86.8%
- Insiders 10.2%
- Public and other 3.1%
Who owns OnKure Therapeutics stock?
Institutional investors own about 86.8% of OnKure Therapeutics's shares, spread across 101 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 10.17% of OKUR.
The largest institutional holders are RA Capital Management, L.P. (9.90%), BVF Inc. (8.01%) and Acorn Capital Advisors, LLC (7.03%). Together, the top 10 institutions control 57.2% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their OKUR positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of OKUR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 4.00M | 9.90% | 0.0% |
| BVF Inc. | 3.24M | 8.01% | +63.5% |
| Acorn Capital Advisors, LLC | 2.84M | 7.03% | 0.0% |
| StepStone Group LP | 2.66M | 6.59% | 0.0% |
| Adar1 Capital Management, LLC | 2.24M | 5.54% | -8.1% |
| Vivo Capital, LLC | 1.93M | 4.77% | 0.0% |
| Vestal Point Capital, LP | 1.83M | 4.52% | -0.8% |
| Blackrock Inc. | 1.50M | 3.71% | +2924.7% |
| Trails Edge Capital Partners, LP | 1.44M | 3.56% | +100.0% |
| Vanguard Capital Management LLC | 1.44M | 3.56% | +146.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of OKUR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.11M | 2.75% |
| iShares Trust-iShares Russell 2000 ETF | 560.52K | 1.39% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 302.42K | 0.75% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 285.51K | 0.71% |
| iShares Trust-iShares Russell 2000 Value ETF | 225.39K | 0.56% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 135.80K | 0.34% |
| iShares Trust-iShares Micro-Cap ETF | 86.97K | 0.22% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 78.01K | 0.19% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 63.64K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 57.15K | 0.14% |
Frequently asked questions
Who is the largest shareholder of OnKure Therapeutics?
RA Capital Management, L.P. is the largest institutional shareholder of OKUR, owning 9.90% of shares outstanding (4.00M shares) as of its latest 13F filing.
What percentage of OnKure Therapeutics is owned by institutions?
Institutions own about 86.8% of OKUR shares and 96.6% of the public float.
How much of OnKure Therapeutics do insiders own?
Insiders, such as officers and directors, own about 10.17% of OKUR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.